Phase III Study of Adefovir Dipivoxil Tablets in Patients With Compensated Chronic Hepatitis B -Comparative Study Against Lamivudine-.

Trial Profile

Phase III Study of Adefovir Dipivoxil Tablets in Patients With Compensated Chronic Hepatitis B -Comparative Study Against Lamivudine-.

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Dec 2016

At a glance

  • Drugs Adefovir dipivoxil (Primary) ; Lamivudine
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 13 Oct 2009 Actual end date (Jan 2008) added as reported by ClinicalTrials.gov.
    • 09 Apr 2008 Status changed from in progress to completed according to ClinicalTrials.gov.
    • 18 Jan 2007 Status changed from recruiting
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top